TWC — 6th Theranostics World Congress

Radiomolecular Precision Theranostics: The Patient, Molecule and Dose. In 2011, a nuclear medicine physician and a radiochemist, namely Prof. Dr. Richard P. Baum and Prof. Dr. Frank Rösch, founded the very first Theranostics World Congress (TWC) in the field of nuclear medicine covering the topics Gallium-68 and Peptide Receptor Radionuclide Therapy - THERANOSTICS – on the Way to Personalized Medicine. Since then, the TWC has developed as the most important forum for mutual exchange and a true bench to bedside view on scientific and clinical developments. With this 360° perspective on Theranostics and Radiomolecular Precision Oncology, the TWC is truly a platform for all players in this exciting field. And this worldwide! From Europe to India over America to Australia and Asia, the TWC was held in several venues around the world.

Topics: Radiochemistry and radioisotope production, Prostate cancer theranostics, Neuroendocrine tumors theranostics, Tumor microenvironment (TME), Novel (and old) targets, Combination therapies, Targeted radiation therapy and (pharmaco)genetics, Artificial intelligence-based theranostics, Clinical trials for novel radiopharmaceuticals